Practice Parameter for the Assessment and Treatment of Children and Adolescents With Depressive Disorders

ABSTRACT This practice parameter describes the epidemiology, clinical picture, differential diagnosis, course, risk factors, and pharmacological and psychotherapy treatments of children and adolescents with major depressive or dysthymic disorders. Side effects of the antidepressants, particularly th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Academy of Child and Adolescent Psychiatry 2007-11, Vol.46 (11), p.1503-1526
Hauptverfasser:	Birmaher, Boris, M.D, Brent, David, M.D
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult and adolescent clinical studies Antidepressants Biological and medical sciences Child Child clinical studies Child, Preschool Clinical medicine Depression Depressive Disorder, Major - drug therapy Depressive Disorder, Major - epidemiology Depressive Disorder, Major - therapy dysthymic disorder Epidemiology evaluation Female Humans major depressive disorder Male Medical sciences Medical treatment Mental depression Mood disorders Neuropharmacology Pediatrics Pharmacology. Drug treatments practice parameter Practice Patterns, Physicians Prevalence Psychiatry Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Psychotherapy Psychotic Disorders - diagnosis Psychotic Disorders - epidemiology Psychotic Disorders - therapy selective serotonin reuptake inhibitors treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	ABSTRACT This practice parameter describes the epidemiology, clinical picture, differential diagnosis, course, risk factors, and pharmacological and psychotherapy treatments of children and adolescents with major depressive or dysthymic disorders. Side effects of the antidepressants, particularly the risk of suicidal ideation and behaviors are discussed. Recommendations regarding the assessment and the acute, continuation, and maintenance treatment of these disorders are based on the existent scientific evidence as well as the current clinical practice.
ISSN:	0890-8567 1527-5418
DOI:	10.1097/chi.0b013e318145ae1c